Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
7
×
life sciences
national blog main
national top stories
new york top stories
biotech
clinical trials
national
new york blog main
san francisco top stories
boston blog main
fda
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe top stories
indiana blog main
indiana top stories
novartis
startups
amgen
bristol-myers squibb
cancer
europe blog main
gene therapy
glaxosmithkline
ipo
What
bio
roundup
fda
medicines
new
ceo
covid
days
drug
drugs
ipo
acquisitions
activity
advanced
aims
alliance
announced
approvals
approved
arrival
atrophy
august
award
backed
biogen
biotech
bristol
busy
buy
calls
cancer
cause
changing
clamped
collabs
color
crispr
daily
daniel
data
Language
unset
7
×
Current search:
biogen
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
3 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More